日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Outcomes of micropulse transscleral cyclophotocoagulation using different sweep velocity in the treatment of refractory glaucoma

采用不同扫描速度的微脉冲经巩膜睫状体光凝术治疗难治性青光眼的疗效

Jiravarnsirikul, Anuwat; Jiamjira-Anon, Natticha; Ruangvaravate, Ngamkae; Sakiyalak, Darin; Kitnarong, Naris; Phongsuphan, Theerajate; Sermsripong, Wasawat; Petchyim, Sakaorat

Real-world impact of latanoprostene bunod ophthalmic solution 0.024% in glaucoma therapy: a narrative review

拉坦前列素布诺滴眼液0.024%在青光眼治疗中的真实世界影响:一项叙述性综述

Stamer, W Daniel; Chiu, Thomas; Lu, Da-Wen; Wang, Tsing Hong; Rojanapongpun, Prin; Ruangvaravate, Ngamkae; Jo, Youn Hye; Moster, Marlene R; Fingeret, Murray; Cothran, Nora Lee; Steen, Jessica; Gaddie, Ian Benjamin; Uçakhan-Gündüz, Ömür; Shamseldin Shalaby, Wesam; Hutnik, Cindy M L

A Pooled Assessment of Ocular Surface Disease After Switching from Preserved Prostaglandins to Tafluprost Across Six Countries in Asia

亚洲六个国家从含防腐剂的前列腺素换用他氟前列素后眼表疾病的汇总评估

Tumbocon, Joseph Anthony; Wong, Tina T; Sangapillai, Thanendthire; Yen, Yung-Chang; Park, Sang-Woo; Lim, Hsien Han; Ruangvaravate, Ngamkae

Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients

青光眼患者从其他前列腺素类药物换用他氟前列素和无防腐剂他氟前列素后眼表的变化

Ruangvaravate, Ngamkae; Choojun, Karnthida; Srikulsasitorn, Benjawan; Chokboonpiem, Jatupol; Asanatong, Dechathon; Trakanwitthayarak, Supaporn

Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study

0.3%羟丙基甲基纤维素/葡聚糖与0.18%透明质酸钠治疗青光眼患者眼表疾病的疗效比较:一项随机、双盲、对照研究

Prabhasawat, Pinnita; Ruangvaravate, Ngamkae; Tesavibul, Nattaporn; Thewthong, Maneerat